65 related articles for article (PubMed ID: 10520714)
1. Whole-remnant and maximum-voxel SPECT/CT dosimetry in
Mínguez P; Flux G; Genollá J; Delgado A; Rodeño E; Sjögreen Gleisner K
Med Phys; 2016 Oct; 43(10):5279-5287. PubMed ID: 28105713
[TBL] [Abstract][Full Text] [Related]
2. Absorbed dose coefficients for pediatric differentiated thyroid cancer patients undergoing radioiodine therapy.
Kwon TE; Kitahara CM; Lee C
J Radiol Prot; 2024 Feb; 44(1):. PubMed ID: 38232407
[TBL] [Abstract][Full Text] [Related]
3. An indirect high iodine (
Al-Shakhrah IA
J Appl Clin Med Phys; 2020 Jul; 21(7):173-180. PubMed ID: 32573916
[TBL] [Abstract][Full Text] [Related]
4. Analysis of Residence Time, Effective Half-Life, and Internal Dosimetry Before Radioiodine Therapy.
Oliveira CV; Camozzato TSC; Dorow PF; Pasqueta J
J Nucl Med Technol; 2022 Sep; 50(3):233-239. PubMed ID: 36215644
[TBL] [Abstract][Full Text] [Related]
5. Occupational exposure and radiobiological risk from thyroid radioiodine therapy in Saudi Arabia.
Al-Mohammed HI; Sulieman A; Mayhoub FH; Salah H; Lagarde C; Alkhorayef M; Aldhebaib A; Kappas C; Bradley DA
Sci Rep; 2021 Jul; 11(1):14557. PubMed ID: 34267237
[TBL] [Abstract][Full Text] [Related]
6. Investigation of the Importance of Applying Various Methods of Calculation in Determining the Blood-Absorbed Dose for Patients with Differentiated Thyroid Carcinoma.
Al-Shakhrah IA
J Nucl Med Technol; 2023 Dec; 51(4):296-301. PubMed ID: 37433678
[TBL] [Abstract][Full Text] [Related]
7. Effective method of measuring the radioactivity of [ 131I]-capsule prior to radioiodine therapy with significant reduction of the radiation exposure to the medical staff.
Lützen U; Zhao Y; Marx M; Imme T; Assam I; Siebert FA; Culman J; Zuhayra M
J Appl Clin Med Phys; 2016 Jul; 17(4):59-72. PubMed ID: 27455475
[TBL] [Abstract][Full Text] [Related]
8. Individualized dosimetry in children and young adults with differentiated thyroid cancer undergoing iodine-131 therapy.
Kumar P; Damle NA; Agarwala S; Dwivedi SN; Bal C
J Pediatr Endocrinol Metab; 2020 Jul; ():. PubMed ID: 32651987
[TBL] [Abstract][Full Text] [Related]
9. Measurements of 131I activity in thyroid of workers at the place of radioiodine therapy in 38 hospitals in China.
Li XL; Zhang JF; Wang S; Liu JX; Tuo F; Sun QF
J Radiat Res; 2024 May; ():. PubMed ID: 38818645
[TBL] [Abstract][Full Text] [Related]
10. Should we reconsider blocking the thyroid for 123 I-Ioflupane studies in elderly patients: quantifying radiation dose to the unblocked thyroid and implications for clinical practice.
Morton DWA; Vennart N; Slinger H; Gannon M; Razvi S; Bartholomew P
Nucl Med Commun; 2024 Feb; 45(2):108-114. PubMed ID: 37901928
[TBL] [Abstract][Full Text] [Related]
11. Out-of-Field Dose Measurement by TLD Dosimetry and Estimation of Radiation-Induced Secondary Cancer Risk of Thyroid and Breast from Head Radiotherapy.
Rahbar Yazdi S; Zare MH; Broomand MA
J Biomed Phys Eng; 2023 Oct; 13(5):403-410. PubMed ID: 37868945
[TBL] [Abstract][Full Text] [Related]
12. Radiation exposure levels in family members of omani patients with thyrotoxicosis treated with radioiodine (I) as outpatients.
Al-Maskery I; Bererhi H
Sultan Qaboos Univ Med J; 2009 Aug; 9(2):148-52. PubMed ID: 21509291
[TBL] [Abstract][Full Text] [Related]
13. Effect of Amifostine on Sperm DNA Fragmentation and Testes after Radioiodine Treatment.
Cebi Sen C; Yumusak N; Atilgan HI; Sadic M; Koca G; Korkmaz M
J Vet Res; 2017 Dec; 61(4):509-515. PubMed ID: 29978117
[TBL] [Abstract][Full Text] [Related]
14. Sperm DNA fragmentation after radioiodine treatment for differentiated thyroid cancer.
Esquerré-Lamare C; Isus F; Moinard N; Bujan L
Basic Clin Androl; 2015; 25():8. PubMed ID: 26236480
[TBL] [Abstract][Full Text] [Related]
15. Expression and localization of the sodium/iodide symporter (NIS) in testicular cells.
Russo D; Scipioni A; Durante C; Ferretti E; Gandini L; Maggisano V; Paoli D; Verrienti A; Costante G; Lenzi A; Filetti S
Endocrine; 2011 Aug; 40(1):35-40. PubMed ID: 21499816
[TBL] [Abstract][Full Text] [Related]
16. Radiation dose to the testes after 131I therapy for ablation of postsurgical thyroid remnants in patients with differentiated thyroid cancer.
Ceccarelli C; Battisti P; Gasperi M; Fantuzzi E; Pacini F; Gualdrini G; Pierantoni MC; Luciani A; Djokich D; Pinchera A
J Nucl Med; 1999 Oct; 40(10):1716-21. PubMed ID: 10520714
[TBL] [Abstract][Full Text] [Related]
17. Testicular function after 131I therapy for hyperthyroidism.
Ceccarelli C; Canale D; Battisti P; Caglieresi C; Moschini C; Fiore E; Grasso L; Pinchera A; Vitti P
Clin Endocrinol (Oxf); 2006 Oct; 65(4):446-52. PubMed ID: 16984236
[TBL] [Abstract][Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
